Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Azevan Pharmaceuticals

Clinical trials sponsored by Azevan Pharmaceuticals, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a pill tame aggression in fragile x? new trial aims to find out Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

Could a pill tame aggression in fragile x? new trial aims to find out

Symptom relief Not yet recruiting

This study tests whether the drug SRX246 can reduce irritability, aggression, and self-injury in adult males with Fragile X syndrome. Eighty participants will take either SRX246 or a placebo daily for up to 8 months, with regular check-ins by phone or home visits. The goal is to …

Phase 2 • Sponsor: Azevan Pharmaceuticals • Aim: Symptom relief

Last updated Jun 27, 2026 08:09 UTC